Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 383

Results For "EU"

4774 News Found

Azelis expands partnership with Roquette to strengthen India presence
News | February 24, 2022

Azelis expands partnership with Roquette to strengthen India presence

This new mandate builds upon and strengthens Azelis and Roquette’s global strategic partnership which spans multiple regions and industries.


Industry needs to ensure quality standards : S Aparna, Union Pharma Secretary
News | February 24, 2022

Industry needs to ensure quality standards : S Aparna, Union Pharma Secretary

Collaboration in the industry needs to be institutionalised to drive the growth.


Omicron sublineage BA.2 a Variant of Concern: WHO
News | February 23, 2022

Omicron sublineage BA.2 a Variant of Concern: WHO

As part of its on-going work to track variants, WHO's Technical Advisory Group on SARS-CoV-2 Virus Evolution (TAG-VE) discussed the latest evidence on the Omicron variant of concern


MicroLumix’ GermPass kills Covid-19 virus in five seconds
Medical Device | February 23, 2022

MicroLumix’ GermPass kills Covid-19 virus in five seconds

New biotechnology product aims to be world's fastest automatic sanitary solution


Sumitomo Dainippon Pharma Oncology appoints Jatin J. Shah as Chief Medical Officer
People | February 23, 2022

Sumitomo Dainippon Pharma Oncology appoints Jatin J. Shah as Chief Medical Officer

Dr. Shah will lead strategic and operational clinical development of the company's diverse pipeline


Medtronic receives USFDA approval for InterStim X system to manage bladder and bowel control
Medical Device | February 23, 2022

Medtronic receives USFDA approval for InterStim X system to manage bladder and bowel control

New InterStim X system provides 10 to 15 years of battery life without the need to recharge


Taro to Acquire Alchemee from Galderma
Biotech | February 23, 2022

Taro to Acquire Alchemee from Galderma

Alchemee's flagship brand Proactiv@ is an iconic product synonymous with acne care


ACUITE upgrades ratings of Bal Pharma
News | February 23, 2022

ACUITE upgrades ratings of Bal Pharma

The group had witnessed healthy revenue growth as revenue stood at Rs 251.14 crore in FY21.


Biorchestra announces US$45 million series C fundraising
News | February 23, 2022

Biorchestra announces US$45 million series C fundraising

he financing was significantly oversubscribed with high demand from both existing and new investors.


Vicore advances on new chemical entity from VP03 program
News | February 23, 2022

Vicore advances on new chemical entity from VP03 program

Four additional AT2R agonists are expected to finalize preclinical evaluation during 2022